Oral tranexamic acid can help some people with melasma, but it is not suitable for everyone and should not be started as a skin-brightening supplement. A clinician needs to confirm the diagnosis, review clotting risks and medicines, and explain alternatives before prescribing. Its use for melasma is described as off-label in Indian expert guidance; the prescribing doctor should confirm the current local product information.
A tablet and a serum with the same ingredient name are not interchangeable. Neither a friend's result nor the strength printed on a skincare bottle establishes whether oral treatment is appropriate for you.
What does tranexamic acid do?
Tranexamic acid is an antifibrinolytic medicine: in its established medical uses, it reduces the breakdown of blood clots. Its proposed effects in melasma involve signalling pathways that influence pigment production, rather than physically removing an existing patch. The precise dermatological mechanism is not fully understood. DermNet explains its medical uses and proposed actions.
That mechanism is why oral treatment requires a different conversation from trying a cosmetic moisturiser. Ask the prescriber to name the problem being treated, explain why this medicine is being considered now and describe how the benefit will be judged.
When might it be considered for melasma?
Melasma treatment commonly starts with sun protection and appropriate topical medicines. Selected procedures may sometimes be added, but no single treatment is best for everyone. The American Academy of Dermatology's guidance describes this individual approach.
Oral tranexamic acid may be discussed when melasma remains troublesome despite other measures and the person's risk profile is suitable. It is not evidence that topicals are useless or that every patient needs a tablet. At the consultation, bring details of what you have actually used, how consistently and whether irritation interrupted the plan.
What does “off-label” mean here?
Off-label use means using a medicine outside an approved indication; it does not mean there is no research. It also does not mean that evidence for one condition automatically proves safety for a different use.
A 2023 consensus statement from Indian experts describes oral tranexamic acid for melasma as off-label and recommends informed consent, careful selection and a full medical history. The paper summarises studies reporting benefit but also identifies uncertainty about the optimal duration. This article deliberately does not provide a dose or a self-treatment schedule.
Ask for that discussion in plain language. You should understand what is known, what remains uncertain and why the prescriber considers the trade-off reasonable for your circumstances.
Who needs particular caution or should avoid it?
The Indian consensus advises against oral tranexamic acid for people with active thromboembolic disease, a history or risk of thrombosis, and women using combination hormonal contraception. A previous allergic reaction also matters. Do not stop contraception on your own to make yourself eligible for a cosmetic treatment.
Kidney problems, a history of seizures, pregnancy or plans for pregnancy, and other medical conditions need review. The NHS suitability guidance lists important factors to disclose. Safety screening is not a box that can be replaced by “I feel healthy.”
| Bring to the consultation | What to clarify |
|---|---|
| All medicines and contraceptives | Whether any combination makes oral treatment unsuitable. |
| Personal and family clotting history | Whether further assessment or a different treatment is needed. |
| Previous kidney, seizure or other significant medical problems | How these affect the risk discussion. |
| Previous melasma prescriptions and photographs | Whether the diagnosis and earlier response support this option. |
Which symptoms need urgent attention?
Seek emergency care for sudden breathing difficulty, chest pain or coughing blood. A painful, swollen limb can also signal a blood clot and needs urgent assessment. Serious allergic symptoms, such as swelling affecting breathing, require emergency help. Do not wait for a pigmentation follow-up. The NHS explains serious adverse effects and their warning signs.
Ask the prescriber which non-urgent symptoms to report too, and whom to contact between appointments. Keep the medicine packaging and prescription available if you need medical care elsewhere.
How long does improvement take, and can melasma return?
Response is assessed over weeks to months, not a few days. Improvement is not a permanent cure: melasma may recur after treatment. Long-term oral use should not be assumed safe simply because an initial course was tolerated; DermNet notes limitations in long-term safety information.
Before starting, agree on a review date, comparable photographs and criteria for continuing, changing or stopping treatment. Include the cost of reviews and the accompanying skincare plan. A photograph in brighter lighting is not enough to establish that pigment has improved.
What if tablets are unsuitable?
A dermatologist can discuss topical options, photoprotection and whether any procedure has a reasonable role. Choosing not to use oral tranexamic acid does not mean there is no way to manage melasma.
Skinoq's skin treatment service includes pigmentation concerns. Use the consultation to compare suitable options, not to request a particular tablet before your history has been reviewed.
Frequently asked questions
Can I use tablets prescribed previously for heavy periods?
No. A prescription for one problem is not a melasma plan. Do not reuse it or change its purpose without the prescribing clinician.
Does an oral-treatment warning automatically apply to my serum?
Not in the same way. Route, formulation and exposure differ. Show the actual product to your clinician rather than assuming either identical risk or complete safety.
Should I have a blood test before starting?
The clinician should decide which assessment is indicated from your history. A normal test result alone does not replace a review of clotting risk and medicines.
Discuss the risk and benefit for your skin
See Skinoq's centre details for Surat and Ahmedabad and request a pigmentation consultation at Piplod, Pal or Bodakdev. Bring your current medicines and earlier treatment records.
By Skinoq Editorial. Educational information only. Do not start, repurpose or change prescription treatment without medical advice.
